Literature DB >> 22269305

CAGS and ACS Evidence Based Reviews in Surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis.

Steve Latosinsky1, Tanya S Berrang, C Suzanne Cutter, Ralph George, Ivo Olivotto, Thomas B Julian, Allen Hayashi, Christopher Baliski, Randall L Croshaw, Kathleen M Erb, Jennifer Chen.   

Abstract

Entities:  

Year:  2012        PMID： 22269305      PMCID： PMC3270088          DOI： 10.1503/cjs.036011

Source DB:  PubMed          Journal:  Can J Surg        ISSN： 0008-428X            Impact factor:   2.089


× No keyword cloud information.
  9 in total

1.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Authors:  Bernard Fisher; Jong-Hyeon Jeong; Stewart Anderson; John Bryant; Edwin R Fisher; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

2.  Evidence-based medicine. A new approach to teaching the practice of medicine.

Authors: 
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

3.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Douglas G Altman; Stuart J Pocock; Stephen J W Evans
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

4.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Authors:  David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Joseph P Costantino; Takamaru Ashikaga; Donald L Weaver; Eleftherios P Mamounas; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; André Robidoux; Hugh Mc Scarth; Norman Wolmark
Journal:  Lancet Oncol       Date:  2010-10       Impact factor: 41.316

5.  Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Authors:  V M Duric; M R Stockler; S Heritier; F Boyle; J Beith; A Sullivan; N Wilcken; A S Coates; R J Simes
Journal:  Ann Oncol       Date:  2005-08-26       Impact factor: 32.976

6.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

7.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

8.  Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial.

Authors:  Marieke E Straver; Philip Meijnen; Geertjan van Tienhoven; Cornelis J H van de Velde; Robert E Mansel; Jan Bogaerts; Nicole Duez; Luigi Cataliotti; Jean H G Klinkenbijl; Helen A Westenberg; Huub van der Mijle; Marko Snoj; Coen Hurkmans; Emiel J T Rutgers
Journal:  Ann Surg Oncol       Date:  2010-03-19       Impact factor: 5.344

9.  Impact of axillary lymph node dissection on the therapy of breast cancer patients.

Authors:  P P Lin; D C Allison; J Wainstock; K D Miller; W C Dooley; N Friedman; R R Baker
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544
  9 in total
  13 in total

Review 1.  The Adventure of Axillary Treatment in Early Stage Breast Cancer.

Authors:  Bekir Kuru
Journal:  Eur J Breast Health       Date:  2020-01-01

2.  Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

Authors:  Armando E Giuliano; Monica Morrow; Shivani Duggal; Thomas B Julian
Journal:  Clin Exp Metastasis       Date:  2012-08-29       Impact factor: 5.150

3.  Role of Combined Sentinel Lymph Node Biopsy and Axillary Node Sampling in Clinically Node-Negative Breast Cancer.

Authors:  K J Edwards; M A Dordea; R French; V Kurup
Journal:  Indian J Surg       Date:  2015-06-24       Impact factor: 0.656

Review 4.  Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trial.

Authors:  Toralf Reimer; Steffi Hartmann; Angrit Stachs; Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2014-05       Impact factor: 2.860

5.  Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer.

Authors:  Antonio Piñero; Manuel Canteras; Arancha Moreno; Francisco Vicente; Julia Giménez; Ana Tocino; Edelmiro Iglesias; Sergi Vidal-Sicart; Luzdivina Santamaría; Miguel Lorenzo; Manuel García; Diego Ramirez
Journal:  Clin Transl Oncol       Date:  2012-07-25       Impact factor: 3.405

Review 6.  Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis.

Authors:  Rachna Ram; Jasprit Singh; Eddie McCaig
Journal:  Int J Breast Cancer       Date:  2014-10-14

7.  The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study.

Authors:  Miao Liu; Shu Wang; Shude Cui; Xuening Duan; Zhimin Fan; Zhigang Yu
Journal:  Sci Rep       Date:  2015-10-16       Impact factor: 4.379

8.  Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

Authors:  Jana de Boniface; Jan Frisell; Yvette Andersson; Leif Bergkvist; Johan Ahlgren; Lisa Rydén; Roger Olofsson Bagge; Malin Sund; Hemming Johansson; Dan Lundstedt
Journal:  BMC Cancer       Date:  2017-05-26       Impact factor: 4.430

Review 9.  Incidental axillary dose delivery to axillary lymph node levels I-III by different techniques of whole-breast irradiation: a systematic literature review.

Authors:  Martin Schmitt; Yvan Pin; Carole Pflumio; Carole Mathelin; Xavier Pivot; Georges Noel
Journal:  Strahlenther Onkol       Date:  2021-07-22       Impact factor: 3.621

10.  Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method.

Authors:  F Di Filippo; D Giannarelli; C Bouteille; L Bernet; R Cano; G Cunnick; A Sapino
Journal:  J Exp Clin Cancer Res       Date:  2015-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.